Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia

Infection Control and Hospital Epidemiology

Volumn 28, Issue 4, 2007, Pages 389-397

  Verhamme, K M C ^a,b   De Coster, W ^a   De Roo, L ^a   De Beenhouwer, H ^a   Nollet, G ^a   Verbeke, J ^a   Demeyer, I ^a   Jordens, P ^a  

^a OLV HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER; ADULT; AGED; ARTICLE; BURKHOLDERIA; CITROBACTER; CONTROLLED STUDY; ENTEROBACTER; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORGANELLA MORGANII; PATHOGENESIS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 34247533752     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/511702     Document Type: Article

References (22)

1. Bowton DL. Nosocomial pneumonia in the ICU - year 2000 and beyond. Chest 1999; 115:28S-33S.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644.
3. Leroy O, Soubrier S. Hospital-acquired pneumonia: risk factors, clinical features, management, and antibiotic resistance. Curr Opin Pulm Med 2004; 10:171-175.
4. National Surveillance of Infection in Hospitals Web site. Available at: http://www.nsih.be. Accessed February 16, 2007.
5. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122:2183-2196.
6. Infectious Diseases Advisory Board. Diagnosis and Antibacterial Treatment of VAP. Belgium; 2002.
7. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539.
8. Hospitals in Europe Link for Infection Control Through Surveillance Web site. Available at: http://helics.univ-lyon1.fr/home.htm. Accessed February 16, 2007.
9. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
10. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005; 50:742-765.
11. Bonten MJ, Bergmans DC, Ambergen AW, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996; 154:1339-1346.
12. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19:256-264.
13. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 1998; 158:1839-1847.
14. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613.
15. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117:1434-1442.
16. Akca O, Koltka K, Uzel S, Cakar N, et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 2000; 93:638-645.
17. Leroy O, Meybeck A, d'Escrivan T, Devos P, Kipnis E, Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 2003; 29:2170-2173.
18. Giantsou E, Liratzopoulos N, Efraimidou E, et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med 2005; 31:1488-1494
19. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
20. Fagon JY, Chastre J. Antimicrobial treatment of hospital-acquired pneumonia. Clin Chest Med 2005; 26:97-104.
21. Niederman MS. The clinical diagnosis of ventilator-associated pneumonia. Respir Care 2005; 50:788-796.
22. Baughman RP. Microbiologic diagnosis of ventilator-associated pneumonia. Clin Chest Med 2005; 26:81-86.